BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 351715)

  • 1. Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome.
    Vincenti F; Goldberg LI
    Prostaglandins; 1978 Mar; 15(3):463-72. PubMed ID: 351715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of the hepatorenal syndrome with intra-renal administration of prostaglandin E1.
    Zusman RM; Axelrod L; Tolkoff-Rubin N
    Prostaglandins; 1977 May; 13(5):819-30. PubMed ID: 866693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.
    Saló J; Ginès A; Quer JC; Fernández-Esparrach G; Guevara M; Ginès P; Bataller R; Planas R; Jiménez W; Arroyo V; Rodés J
    J Hepatol; 1996 Dec; 25(6):916-23. PubMed ID: 9007721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prostaglandin a1 on acute renal failure in the rat.
    Cioffi RF; O'Connell B; Shalhoub RJ
    Nephron; 1975; 15(1):29-34. PubMed ID: 1128755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and frusemide in oliguric acute renal failure.
    Graziani G; Cantaluppi A; Casati S; Citterio A; Scalamogna A; Aroldi A; Silenzio R; Brancaccio D; Ponticelli C
    Nephron; 1984; 37(1):39-42. PubMed ID: 6717704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to dopamine hydrochloride in the hepatorenal syndrome.
    Bennett WM; Keeffe E; Melnyk C; Mahler D; Rösch J; Porter GA
    Arch Intern Med; 1975 Jul; 135(7):964-71. PubMed ID: 1156055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and renal salvage in the critically ill patient.
    Duke GJ; Bersten AD
    Anaesth Intensive Care; 1992 Aug; 20(3):277-87. PubMed ID: 1524166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure.
    Shaw S; Weidmann P; Zimmermann A
    Kidney Int; 1992 Nov; 42(5):1153-9. PubMed ID: 1453600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low dosage dopamine improves kidney function: current status of knowledge and evaluation of a controversial topic].
    Kindgen-Milles D; Tarnow J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Jun; 32(6):333-42. PubMed ID: 9333327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine hydrochloride in oliguric states.
    Henderson IS; Beattie TJ; Kennedy AC
    Lancet; 1980 Oct; 2(8199):827-8. PubMed ID: 6107501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-frusemide therapy in acute renal failure.
    Graziani G; Casati S; Cantaluppi A; Citterio A; Aroldi A; Scalamogna A; Brancaccio D; Ponticelli C
    Proc Eur Dial Transplant Assoc; 1983; 19():319-24. PubMed ID: 6878248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuresis and improved renal hemodynamics produced by prostaglandin E1 in the dog with norepinephrine-induced acute renal failure.
    Moskowitz PS; Korobkin M; Rambo ON
    Invest Radiol; 1975; 10(4):284-99. PubMed ID: 1102487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the action and interaction of dopamine and prostaglandin A1 in the renal vasculature.
    Pendleton RG; Woodward PW
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):250-60. PubMed ID: 9038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostaglandin A2 and E2 on renal function and renin release.
    Matsumura T; Kishimoto T; Maeda T; Maekawa M; Abe Y; Yamamoto K
    Jpn Circ J; 1978 Aug; 42(8):927-38. PubMed ID: 731834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proceedings: Natriuresis and renal hemodynamics during the administration of prostaglandin A2 in essential hypertension].
    Toyama T; Murakami K; Sato T; Imura Y; Tofuku Y
    Jpn Circ J; 1975 Jun; 39(6):744. PubMed ID: 1152273
    [No Abstract]   [Full Text] [Related]  

  • 17. Is renal dose dopamine protective or therapeutic? No.
    Cottee DB; Saul WP
    Crit Care Clin; 1996 Jul; 12(3):687-95. PubMed ID: 8839600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
    Kövér G; Fekete M; Tost H; Szemerédi K
    Acta Physiol Hung; 1988; 72(3-4):321-33. PubMed ID: 3250211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine in the hepatorenal syndrome.
    Wilson JR
    JAMA; 1977 Dec; 238(25):2719-20. PubMed ID: 579213
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure.
    Lindner A
    Nephron; 1983; 33(2):121-6. PubMed ID: 6835459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.